4.6 Article

TRAF6 signaling pathway in T cells regulates anti-tumor immunity through the activation of tumor specific Th9 cells and CTLs

Related references

Note: Only part of the references are listed.
Article Oncology

TGF-β1 Induces Immune Escape by Enhancing PD-1 and CTLA-4 Expression on T Lymphocytes in Hepatocellular Carcinoma

Shixiang Bao et al.

Summary: Primary liver cancer is one of the most common types of cancer worldwide, with hepatocellular carcinoma accounting for the majority of cases. Immunotherapy targeting the HCC microenvironment has shown effectiveness in treatment, with studies indicating that TGF-beta 1 can regulate the expression of PD-1 and CTLA-4 on T lymphocytes, impacting their cytotoxicity towards HCC cells.

FRONTIERS IN ONCOLOGY (2021)

Review Immunology

Immune checkpoint blockade in infectious diseases

Michelle N. Wykes et al.

NATURE REVIEWS IMMUNOLOGY (2018)

Review Immunology

TH9 cells in anti-tumor immunity

Thaiz Rivera Vargas et al.

SEMINARS IN IMMUNOPATHOLOGY (2017)

Article Immunology

Perforin: structure, function, and role in human immunopathology

Ilia Voskoboinik et al.

IMMUNOLOGICAL REVIEWS (2015)

Article Biochemistry & Molecular Biology

Robust tumor immunity to melanoma mediated by interleukin-9-producing T cells

Rahul Purwar et al.

NATURE MEDICINE (2012)

Article Biochemistry & Molecular Biology

TRAF6 is a T cell-intrinsic negative regulator required for the maintenance of immune homeostasis

Carolyn G. King et al.

NATURE MEDICINE (2006)

Article Immunology

Effector and memory CD8+ T cell fate coupled by T-bet and eomesodermin

AM Intlekofer et al.

NATURE IMMUNOLOGY (2005)

Article Immunology

CD4 T cells in tumor immunity

M Gerloni et al.

SPRINGER SEMINARS IN IMMUNOPATHOLOGY (2005)